← Back to headlines
Cantor Fitzgerald Lowers AbbVie (ABBV) Target Amid Weak Pharma Outlook
Cantor Fitzgerald has reduced its price target for pharmaceutical company AbbVie (ABBV), citing a weak catalyst outlook for the sector.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
